DEA Warns: Fentanyl Now Mixed with Deadlier Synthetic Compounds
DEA issues urgent safety advisory as fentanyl is increasingly combined with xylazine, nitazenes, cychlorphine, and medetomidine—substances that can defeat standard overdose reversal.
The Drug Enforcement Administration (DEA) has issued an urgent public safety warning about a dangerous evolution in the illicit drug supply. Fentanyl—already the leading cause of overdose deaths in the United States—is now increasingly mixed with a cocktail of emerging synthetic substances that make the drug supply more unpredictable, more potent, and harder to reverse.
According to the DEA advisory released June 2, 2026, law enforcement and public health officials are encountering fentanyl combined with substances including xylazine, nitazenes, cychlorphine, and medetomidine. Many of these compounds are not approved for human consumption and are often undetectable to users.
"These combinations are making an already deadly drug supply even more unpredictable and lethal," the DEA stated. "Today's illicit drug supply is more dangerous, more deceptive, and more deadly than ever before. One pill, one try can kill."
What Is Being Mixed with Fentanyl
The DEA has identified four primary classes of substances now appearing in fentanyl seizures nationwide:
Xylazine
Originally developed as a veterinary sedative for large animals, xylazine—often called "tranq" or "zombie drug"—has spread through the illicit opioid supply since 2022. It is not an opioid, meaning naloxone does not reverse its effects. Xylazine also causes severe soft tissue damage, leading to deep wounds that can become infected and, in some cases, require amputation.
Medetomidine
A newer veterinary sedative sometimes called "rhino tranq," medetomidine is chemically similar to xylazine but even more potent. Like xylazine, it is not an opioid and will not respond to naloxone. The CDC issued a Health Alert Network advisory about medetomidine in May 2026 after detecting it in fentanyl samples across multiple states.
Nitazenes
This class of synthetic opioids includes compounds like protonitazene, metonitazene, and isotonitazene. Nitazenes can be significantly more potent than fentanyl—in some cases, hundreds of times stronger. The DEA has identified 22 unique nitazene compounds since 2020, 21 of which are classified as Schedule I controlled substances. Because they are opioids, nitazenes do respond to naloxone, but multiple doses may be required.
Cychlorphine
Another potent synthetic opioid appearing in the drug supply, cychlorphine belongs to a chemical class related to fentanyl but with distinct pharmacological properties. Like nitazenes, it may require higher or repeated doses of naloxone to reverse an overdose.
Why This Matters for Overdose Response
The emergence of these substances fundamentally changes how bystanders and first responders must approach suspected overdoses:
Naloxone May Not Fully Work
When xylazine or medetomidine are present, naloxone will not reverse the sedation and respiratory depression caused by these non-opioid compounds. A person may remain unconscious and have difficulty breathing even after receiving naloxone.
Multiple Doses May Be Needed
For overdoses involving nitazenes or cychlorphine, standard doses of naloxone may be insufficient. The DEA advises that additional doses may be required and that rescue breathing or CPR may be necessary while waiting for emergency medical services.
The Window for Intervention Narrows
Many of these emerging synthetics act faster and last longer than fentanyl alone. This compresses the time available to recognize an overdose, administer naloxone, and call for emergency help.
Recognizing a Complex Overdose
Signs that an overdose may involve substances beyond fentanyl include:
- Severe or prolonged sedation that persists after naloxone administration
- Slow or irregular breathing that continues despite naloxone
- Bluish or grayish skin tone, particularly in extremities
- Severe skin wounds or ulcers (possible sign of chronic xylazine exposure)
- Unresponsiveness for extended periods
If you suspect an overdose, always call 911 immediately. Even if naloxone appears to work, medical evaluation is essential because the sedative effects of xylazine or medetomidine can outlast the naloxone, causing the person to stop breathing again.
What Families and Communities Can Do
Carry Naloxone—and Know Its Limits
Naloxone remains the first-line treatment for suspected opioid overdoses and should be administered immediately. However, understand that it may not fully reverse overdoses involving xylazine or medetomidine. Call 911 regardless of whether naloxone appears to work.
Learn Rescue Breathing
Since naloxone may not fully restore breathing when non-opioid sedatives are present, rescue breathing can be life-saving. Free training is available through many harm reduction organizations and health departments.
Never Use Alone
The DEA emphasizes that using drugs alone dramatically increases fatal overdose risk. If you or a loved one uses substances, never use alone, and ensure someone present has naloxone and knows how to use it.
Test for Fentanyl—With Caution
Fentanyl test strips can detect the presence of fentanyl in drugs, but they cannot detect xylazine, medetomidine, nitazenes, or cychlorphine. A negative fentanyl test does not mean a substance is safe. Note that SAMHSA guidance issued in April 2026 restricts federal funding for fentanyl test strips, though they remain available through many state and local programs.
Assume All Illicit Drugs Are Contaminated
The DEA advises assuming that all counterfeit pills and illicit drugs may contain fentanyl or other deadly additives. Pills purchased online, through social media, or from informal sources are especially risky.
Where to Get Help
If you or someone you love is struggling with substance use, treatment is available and effective:
- SAMHSA National Helpline: 1-800-662-HELP (4357) — Free, confidential, 24/7 treatment referral
- Crisis Text Line: Text HOME to 741741 for immediate support
- 988 Suicide & Crisis Lifeline: Call or text 988 for mental health crises
To find treatment providers in your area, use the SAMHSA Treatment Locator or contact your state substance use agency.
The Bottom Line
The drug supply is evolving faster than ever, with new synthetic compounds making an already dangerous situation more complex. For families and communities, this means:
- Always call 911 for suspected overdose—don't rely solely on naloxone
- Be prepared to provide rescue breathing if the person remains unconscious
- Never use substances alone
- Seek treatment—medications for opioid use disorder (buprenorphine, methadone, naltrexone) reduce overdose risk and support long-term recovery
The DEA's message is clear: "One pill, one try can kill." In an era of increasingly contaminated drug supplies, the safest choice is to avoid illicit substances entirely—and for those struggling with addiction, to seek evidence-based treatment that can provide a path to recovery.
This alert was medically reviewed by Dr. Rachel Bennett, MD, a board-certified addiction medicine physician. If you have questions about overdose response or treatment options, contact the SAMHSA National Helpline at 1-800-662-HELP.
Sources
You might also read
